Association of ENPP1 gene polymorphisms with hand osteoarthritis in a Chuvasha population

Eun-Kyung Suk1, Ida Malkin, Stefan Dahm

  • 1Gene Mapping Center, Max Delbrück Center for Molecular Medicine, Berlin, Germany. anitasuk@aol.com

Insights

Genetic variations in the ENPP1 gene are linked to osteoarthritis of the hand. This study found ENPP1 variability plays a significant role in the development of idiopathic osteoarthritis.

Area of Science:

  • Genetics
  • Rheumatology
  • Molecular Biology

Background:

  • Generalized arterial calcification of infancy is a rare Mendelian disorder linked to mutations in the ENPP1 gene.
  • Periarticular calcification is a common symptom associated with this disorder.
  • The role of ENPP1 in osteoarthritis pathogenesis was previously unclear.

Purpose of the Study:

  • To investigate the association between genetic variations at the ENPP1 locus and the etiology of hand osteoarthritis.
  • To determine if ENPP1 gene variations contribute to the development of idiopathic osteoarthritis.

Main Methods:

  • A family-based association study was conducted with 126 nuclear families (574 individuals).
  • Osteoarthritis extent was assessed using hand radiographs and principal component analysis of 28 joint scores.
  • Genetic analysis involved short tandem repeat (STR) polymorphisms and single-nucleotide polymorphisms (SNPs) at the ENPP1 locus.
  • Transmission disequilibrium tests (TDT) were employed to assess genetic associations.

Main Results:

  • Genetic factors contributed approximately 25% to the overall trait variance of hand osteoarthritis in the studied population.
  • Significant association signals were detected between ENPP1 locus markers and hand osteoarthritis.
  • Specific alleles of an upstream microsatellite marker and several SNP haplotypes showed consistent association with the condition.

Conclusions:

  • Genetic variability in the ENPP1 gene is a significant factor in the pathogenesis of idiopathic osteoarthritis.
  • The findings highlight ENPP1 as a potential genetic target for understanding and potentially treating osteoarthritis.
  • This study provides evidence for the role of ENPP1 in a common, complex disease beyond its known role in rare Mendelian disorders.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
93
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
56
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
72
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
19.4K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.4K
Incomplete Dominance01:43

Incomplete Dominance

Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
32.0K